Archer (ASX:AXE) share price retreats despite positive update

The Archer Materials Ltd (ASX: AXE) share price has retreated in late-afternoon despite announcing a positive update. Here's the details.

| More on:
4DS share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Archer Materials Ltd (ASX: AXE) share price has retreated in late-afternoon trade after soaring as high as 93.5 cents. This comes after the company announced that it has begun to progress on the pathway for sub-10 nanometre biochip fabrication.

At the time of writing, the advanced material company's shares are fetching 90 cents apiece, flat for the day.

Development plans

Archer shares were trading on a high earlier on but have since fallen back to yesterday's market close.

According to its release, Archer advised it has commenced development to produce biochip components that are under 10 nanometres (nm) in size. In comparison, a human hair is around 75 microns or 75,000 nm.

Archer noted that miniaturisation to below 10 nm is a key requirement for the operation and end-use of its biochip. Anything less than 10nm is considered as best-in-class across the semiconductor industry.

The company explained that if successful in creating prototype biochip devices, it would remove significant barriers to entry. This includes pattern design and process optimisation, for on-chip fabrication of biosensor components.

What did the CEO say?

Archer CEO, Dr Mohammad Choucair touched on the company's nanofabrication development, saying:

Archer has progressed to one of the most advanced forms of nanofabrication after recently translating biosensor components onto silicon wafers. We are expanding on this strength with in-house capability to build a robust biochip IP portfolio. This is key to Archer's long-term growth, and near-term speed of execution in its deep tech development.

Best-in-class capabilities in nanofabrication is a global competitive advantage in the multibillion-dollar point of care medical diagnostics industry. One of the reasons why there are few companies in the world developing and commercialising biochips is because it's difficult to achieve precision engineering at the nano scale.

Archer share price summary

Over the past year, the Archer share price has accelerated over 400%, with 75% of those gains coming in 2021 so far. The company's shares reached an all-time high of $1.24 in late February on the back of achieving a technological breakthrough.

Should you invest $1,000 in Commonwealth Bank Of Australia right now?

Before you buy Commonwealth Bank Of Australia shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Commonwealth Bank Of Australia wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 6 March 2025

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

a man with hands in pockets and a serious look on his face stares out of an office window onto a landscape of highrise office buildings in an urban landscape
REITs

Why this could be a great ASX share sector to invest in right now

This could be a smart play right now.

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

How an $8k investment in this ASX All Ords stock one-year ago is worth $58,182 today

The ASX All Ords stock has enjoyed a stellar year. But why?

Read more »

Young girl drinking milk showing off muscles.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors finally caught a break this Friday.

Read more »

A man sits nervously at his computer with his mouth resting against his hands clasped in front of him as he stares at the screen of his computer on a home desk.
Share Market News

It's official: US stock market enters correction

The S&P 500 is now down 10.13% from its most recent peak.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Should you buy the dip on the CSL share price?

Has the market sell-off created an opportunity to buy this mega ASX 200 blue chip at an attractive price?

Read more »

Man with rocket wings which have flames coming out of them.
Broker Notes

Guess which ASX 200 share Bell Potter says could rocket 100%+

The broker thinks this share is seriously undervalued.

Read more »

Four people on the beach leap high into the air.
Share Gainers

4 ASX All Ords stocks shrugging off the looming 2025 market correction and charging higher

If the ASX All Ords enters a 2025 market correction, don’t blame these soaring stocks!

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Catalyst Metals, Droneshield, Liontown, and Northern Star shares are charging higher

These shares are ending the week with a bang. But why?

Read more »